Skip to content

A Prospective Evaluation of Clinical Impact of Physiology versus Optical Coherence Tomography guided PCI in STEMI patients without undergoing primary PCI

A Prospective Evaluation of Clinical Impact of Physiology versus Optical Coherence Tomography guided PCI in STEMI patients without undergoing primary PCI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069148
Enrollment
Unknown
Registered
2023-03-08
Start date
2023-03-30
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction

Interventions

Angio:Determine whether to operate by angiography
OCT:Determine whether PCI treatment is performed through MLA
FFR:FFR was used to determine whether PCI was performed

Sponsors

General Hospital of the Northern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1)Aged 18 to 80 years 2) 7-30 days after STEMI onset 3) PCI was not performed for the following reasons: a.Stabilize the condition in a hospital that cannot provide PCI treatment, and then refer to a tertiary hospital for further evaluation; b.Previous emergency angiography, but no balloon dilation or stent placement; emergency thrombus aspiration, but no balloon dilation or stent placement; 4) After STEMI treatment according to the hospital's standard process, the stenosis degree of the target lesion is 50%-90%, the TIMI blood flow is grade 3, and the patients who have the indication for stent implantation

Exclusion criteria

Exclusion criteria: 1) Left main disease or bypass disease 2) Intolerance to study drugs, metal alloys or contrast agents 3) Life expectancy is less than one year 4) Previous target vessel PCI treatment 5) Previous coronary artery bypass grafting 6) Cardiogenic shock or LVEF90% or <50% 10) Target vessel TIMI blood flow = grade 2 11) There is a surgery plan within 6 months after the starting surgery 12) There are clinical indications that 12 months of DAPT treatment cannot be tolerated 13) Unable to provide written proof of informed consent 14) Patients who participated in other clinical trials at the time of enrollment and did not reach the primary research endpoint

Design outcomes

Primary

MeasureTime frame
target lesion failures;

Secondary

MeasureTime frame
Death;Subacute Thrombosis;myocardial infarc;rehospitalization;

Countries

China

Contacts

Public ContactYaling Han

General Hospital of the Northern Theater Command

hanyaling@263.net+86 024-28851120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026